(Q38116597)

29 August 2017

title

Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia (English)

1 reference

29 August 2017

1 reference

1 reference

Adam R Cole

1

1 reference

29 August 2017

language of work or name

English

0 references

publication date

15 July 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

280

1 reference

29 August 2017

issue

21

1 reference

29 August 2017

page(s)

5213-5227

1 reference

White matter hyperintensities: from medical comorbidities to bipolar disorders and back

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Meta-analysis of thalamic size in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Meta-analysis of regional brain volumes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Pathologies and pathological mechanisms for white matter hyperintensities in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Identifying blood biomarkers for mood disorders using convergent functional genomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A molecular mechanism for the effect of lithium on development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Activation of the Wnt signaling pathway: a molecular mechanism for lithium action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Abnormalities in brain structure and behavior in GSK-3alpha mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

GSK-3beta is required for memory reconsolidation in adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Glycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Developmental expression and localization of glycogen synthase kinase-3beta in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

GSK3 as a Sensor Determining Cell Fate in the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Disruption of two novel genes by a translocation co-segregating with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Common DISC1 polymorphisms disrupt Wnt/GSK3β signaling and brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Activation of protein kinase B (Akt) signaling after electroconvulsive shock in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

5-HT receptors couple to activation of Akt, but not extracellular-regulated kinase (ERK), in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A beta-arrestin 2 signaling complex mediates lithium action on behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Does abnormal sleep impair memory consolidation in schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Ser-557-phosphorylated mCRY2 is degraded upon synergistic phosphorylation by glycogen synthase kinase-3 beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A serine cluster mediates BMAL1-dependent CLOCK phosphorylation and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A hierarchical phosphorylation cascade that regulates the timing of PERIOD nuclear entry reveals novel roles for proline-directed kinases and GSK-3beta/SGG in circadian clocks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A role for the segment polarity gene shaggy/GSK-3 in the Drosophila circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase-3 protein expression in the mouse suprachiasmatic nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A role for glycogen synthase kinase-3beta in the mammalian circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Disruption of circadian rhythmicity and suprachiasmatic action potential frequency in a mouse model with constitutive activation of glycogen synthase kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Lithium impacts on the amplitude and period of the molecular circadian clockwork.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

The ground state of embryonic stem cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

GSK-3 is a master regulator of neural progenitor homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3alpha/beta impairs in vivo neural precursor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Neural stem cell proliferation is decreased in schizophrenia, but not in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Mood stabilizing drugs expand the neural stem cell pool in the adult brain through activation of notch signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Functions of GSK-3 Signaling in Development of the Nervous System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

The Drosophila F box protein archipelago regulates dMyc protein levels in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Shaggy/GSK3 antagonizes Hedgehog signalling by regulating Cubitus interruptus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Proteolysis of the Hedgehog signaling effector Cubitus interruptus requires phosphorylation by Glycogen Synthase Kinase 3 and Casein Kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Expression of Kruppel-like factor 5 gene in human brain and association of the gene with the susceptibility to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

BDNF release from single cells elicits local dendritic growth in nearby neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

c-fos regulates neuronal excitability and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Regulation of GSK3 isoforms by phosphatases PP1 and PP2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A systematic investigation of the protein kinases involved in NMDA receptor-dependent LTD: evidence for a role of GSK-3 but not other serine/threonine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

LTP inhibits LTD in the hippocampus via regulation of GSK3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Glycogen synthase kinase-3 inhibition is integral to long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

GSK-3 beta inhibits presynaptic vesicle exocytosis by phosphorylating P/Q-type calcium channel and interrupting SNARE complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

PP2A-Bgamma subunit and KCNQ2 K+ channels in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Alpha2-chimaerin, cyclin-dependent Kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

No association between the dihydropyrimidinase-related protein 2 (DRP-2) gene and bipolar disorder in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Proteome analysis of schizophrenia brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Bioinformatic prediction and confirmation of beta-adducin as a novel substrate of glycogen synthase kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Spatial regulation of CLASP affinity for microtubules by Rac1 and GSK3beta in migrating epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Glycogen synthase kinase 3 regulates N-methyl-D-aspartate receptor channel trafficking and function in cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

AMPA reduces surface expression of NR1 through regulation of GSK3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Regulation of AMPA receptor trafficking and function by glycogen synthase kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Chronic lithium treatment up-regulates cell surface Na(V)1.7 sodium channels via inhibition of glycogen synthase kinase-3 in adrenal chromaffin cells: enhancement of Na(+) influx, Ca(2+) influx and catecholamine secretion after lithium withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Regulation of serotonin 1B receptor by glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Glycogen synthase kinase-3β is a functional modulator of serotonin-1B receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Protein kinase B/Akt acts via glycogen synthase kinase 3 to regulate recycling of alpha v beta 3 and alpha 5 beta 1 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Strong synaptic transmission impact by copy number variations in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

CACNA1C (rs1006737) is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Association of polymorphisms in HCN4 with mood disorders and obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12407

21 January 2018

Identifiers

DOI

10.1111/FEBS.12407

1 reference

29 August 2017

1 reference